Corrections to “Melanocyte and Keratinocyte Carcinogenesis: p53 Family Protein Activities and Intersecting mRNA Expression Profiles”  by unknown
Melanocyte and Keratinocyte Carcinogenesis: p53 Family Protein Activities and Intersecting mRNA Expression Profiles
Journal of Investigative Dermatology (2007) 127, 1826–1827; doi:10.1038/sj.jid.5700928
Correction to: Journal of Investigative Dermatology Symposium Proceedings (2005) 10, 142–52. doi:10.111/j.1087-0024.
2005.200405.x
In the publication by Kulesz-Martin et al., the authors reported that the TAp63a isoform was expressed in a keratinocyte model
system in vitro, based upon reverse transcription-PCR analysis. We have since confirmed by immunoblotting using isoform-
specific antibodies (provided by Dr Wendy Weinberg) and comparison with known molecular weight p63 isoforms ectopically
expressed in keratinocytes that the TAp63a isoform is not expressed in the keratinocyte model but that the p63 isoforms present
are identical to those in primary keratinocyte cultures. Thus, the p53 family members in keratinocytes are as follows in order of
apparent molecular weight from greatest to least: DNp63a, TAp63b, TAp63g, and either DNp63g or DNp63s with DNp63a
predominating. In the melanocyte model, the p63 isoforms expressed are TAp63g, and either DNp63g or DNp63s with the
lower molecular weight isoform predominating.
The corrected Figures 2, 3 (keratinocytes in left panel), and 5 (summary of changes in p53 family expressions during
carcinogenesis of keratinocytes and melanocytes) are shown. All text in the paper referring to TAp63a expression in
keratinocytes and melanocytes should instead read DNp63a and discussion of TAp63b should read TAp63g, a more
transcriptionally active p63 isoform.
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Corrigenda/Erratum
1826 Journal of Investigative Dermatology (2007), Volume 127
Female Pattern Hair Loss and its Relationship to Permanent/Cicatricial Alopecia: A New Perspective
Journal of Investigative Dermatology (2007) 127, 1827–1828. doi:10.1038/sj.jid.5700950
Correction to: Journal of Investigative Dermatology Symposium Proceedings (2005) 10, 217–221. doi:10.1111/j.1087-0024.
2005.10109.x
In the publication by Olsen, there is an error on page 219. The section title ‘‘Central Center CCCA’’ is incorrect and should
read ‘‘Central Centrifugal Cicatricial Alopecia (CCCA)’’. This section is reprinted here with the correct section title. The
publisher (Blackwell Publishing Inc.) regrets the error.
CENTRAL CENTRIFUGAL CICATRICIAL ALOPECIA (CCCA)
This common type of hair loss was first reported under the term ‘‘hot comb alopecia’’ by LoPresti et al. (1968). This particular
hair loss occurs almost exclusively in African Americans, most commonly in African-American women. As it became apparent
that African-American men may also be affected as well as those individuals who have not used hot combs (a method by which
oiled or greased hair is straightened with a heated iron) (Sperling and Sau, 1992; Sperling et al., 1994; Headington, 1996), the
terminology evolved to ‘‘follicular degeneration syndrome’’ per Sperling and Sau (1992) and more recently to CCCA (Olsen
et al., 2003), the descriptive term adopted by the North American Hair Research Society (NAHRS). Whether hair-grooming
methods specific to the African-American culture, such as hot combs, relaxers, tight braids, heavy extensions, and a variety of
oils and pomades, could cause or at least contribute to the hair loss remains an unsubstantiated assumption.
The hair loss in CCCA begins in the central midline scalp and is slowly progressive centrifugally (Figure 3). The condition
may progress to a Hamilton Norwood Type VI or VII pattern or may only involve the top of the scalp. Inflammation may or may
not be obvious clinically. Perifollicular erythema or follicular keratoses are not typical findings. Histologically, a perivascular
and perifollicular lymphocytic infiltrate, concentric lamellar fibrosis, sebaceous gland loss, as well as premature disintegration
of the internal root sheath are typical (Whiting, 2001a,b). Granulomatous inflammation secondary to follicular rupture may
also be seen (Sperling and Sau, 1992). Recently, these histological findings have been given the moniker of ‘‘pseudopelade’’,
which, unlike the entity of pseudopelade described by Brocq, does not typically have the clinical counterpart of discrete
non-inflammatory patches of hair loss.
No effective therapy for CCCA has been definitively identified. Discontinuation of the use of hot combs, relaxers, and/or
excessive heat, all factors that have been identified as possibly causing this condition, has, in most cases, not led to cessation of
progressive hair loss. Whether hair care products that are used to moisturize the hair and scalp could be etiological factors has
never been addressed. Both bacterial and fungal scalp infections need to be searched for and treated, as these may be
contributing factors. Although anti-inflammatory medications such as topical steroids and/or systemic antibiotics may slow
hair loss in many cases, they are not uniformly effective treatments. Well-controlled clinical trials are needed to address
these issues.
Cell type
p53 family protein
level change
IR or UVB
IR or UVB
IR or UVB
IR or UVB
IR
IR
IR
IR
UVB UVB
UVBUVB
p53No changeNo change
No change
NoneNone p21 and noxap21 and noxap21 and noxa
Cell survivalCellbehavior
Cell cycle arrest
apoptosis
Cell cycle arrest
apoptosis
p21 and noxa gene
transactivation p21
p53
binding
to p21
No DNA binding to 
p21 or noxa
No DNA binding to 
p21 or noxa
No change
To p21:p73 all isoforms,
p63 all isoforms, and p53
p73 all isoforms, p63
all isoforms, and p53
p63 all isoforms,
and p53
Untreated p53 family 
protein expression
Untreated p53 family
DNA binding activity
DNA binding
 activity
03C
Keratinocyte
03R
Keratinocyte
YMM
Melanocyte
1984-1
Melanocyte
p73 N, p63 TA and
(N or S), and p53
p73 TA and N, p63 
N, TA (N or S), and
 p53 binding to p21
To p21:p73 N,
 p63 N, and p53
p73 N p73 N
p73 N, p63 TA and
(N or S), and p53
p73 TA 
binding 
to p21
p73 N
binding 
to p21
and noxa
p73 TA binding 
to p21 p63 TA and
 (N or S) 
binding to p21
To noxa:p63 N only To noxa:p63 N only
p63 N and TA 
binding to noxa
in UVB-treated only 
p63 N binding 
 to noxa
p63 N and TA
binding 
 to noxa
Figure 5
Corrigenda/Erratum
www.jidonline.org 1827
